Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive order to cut prescription drug costs. Last month, Roche said it planned ...

INDIANAPOLIS (WISH) — Officials with pharmaceuticals and diagnostics maker Roche on Monday announced a $550 million investment to expand its diagnostics manufacturing hub in Indianapolis by 2030.

Roche Diagnostics will invest $550 million in its Indianapolis base to construct a new manufacturing facility for glucose monitoring devices, which will add several hundred jobs and further ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning the President Trump administration for an exemption. Roche is trying ...

Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, making the pharmaceutical giant the latest company to unveil a capital ...

April 22 (UPI) --Biotechnology giant Roche said it will invest $50 billion into the United States over the next five years. Roche announced Monday that the financial effort will include new ...

Roche will invest $50 billion in American manufacturing over the next five years, including building a new facility somewhere in Indiana.The Swiss biotech company said the investment will ...

After a near-fatal bike crash in April 2024, ultrarunner David Roche decided to go all in chasing big goals. Five months later, he shattered the Leadville Trail 100 record and now has his sights ...

Roche will partner with Zealand Pharma to co-develop and co-commercialize Zealand’s petrelintide for overweight and obesity indications, the companies said, through a collaboration and licensing ...

Roche is wasting no time in getting out its checkbook in 2025, signing a new biobucks-heavy pact that aims to add another new antibody-drug conjugate (ADC) to its pipeline. Roche, which put ...

Roche's new weight-loss pill, although promising, is not expected to launch before 2028. Analysts estimate that Roche's weight-loss products will only generate around $4 billion in sales by 2032 ...